The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Merrimack Pharmaceuticals Inc

Nasdaq: MACK
Last

(U.S.) $7.08

Today's change0.00 0.00%
Updated April 29 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Merrimack Pharmaceuticals Inc

Nasdaq: MACK
Last

(U.S.) $7.08

Today's change0.00 0.00%
Updated April 29 4:00 PM -4GMT. Delayed by at least 15 minutes.

Merrimack Pharmaceuticals Inc closed at (U.S.)$7.08.

Over the last five days, shares have lost 6.47% and are down 10.38% for the last year to date. This security has underperformed the S&P 500 by 39.13% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $7.08
  • High--
  • Low--
  • Bid / Ask(U.S.) $7.01 / (U.S.) $7.48
  • YTD % change-10.38%
  • Volume0
  • Average volume (10-day)1,557,196
  • Average volume (1-month)1,834,246
  • Average volume (3-month)1,842,188
  • 52-week range(U.S.) $5.02 to (U.S.) $13.26
  • Beta1.94
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.32
Updated April 29 4:00 PM -4GMT. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Biotechnology

Latest Company News

    No News Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue21163715
Total other revenue--------
Total revenue21163715
Gross profit21------
Total cost of revenue0------
Total operating expense64555545
Selling / general / administrative1917129
Research & development45384336
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-43-38-19-30
Interest income (expense), net non-operating-6-4-4-5
Gain (loss) on sale of assets--------
Other--------
Income before tax-48-42-23-34
Income after tax-48-42-23-34
Income tax, total--------
Net income-48-43-23-35
Total adjustments to net income--------
Net income before extra. items-48-43-23-35
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-48-43-23-35
Inc. avail. to common incl. extra. items-48-43-23-35
Diluted net income-48-43-23-35
Dilution adjustment0------
Diluted weighted average shares116112110107
Diluted EPS excluding extraordinary itemsvalue per share-0.41-0.38-0.21-0.32
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.41-0.38-0.21-0.32